These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 23434387)
1. Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial. Klick B; Durrani S; Chan KH; Ip DK; Chou ES; Kwok HK; Ng S; Chiu SS; Peiris JS; Leung GM; Cowling BJ Vaccine; 2013 Apr; 31(15):1937-43. PubMed ID: 23434387 [TBL] [Abstract][Full Text] [Related]
2. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Cowling BJ; Ng S; Ma ES; Fang VJ; So HC; Wai W; Cheng CK; Wong JY; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM Clin Infect Dis; 2012 Sep; 55(5):695-702. PubMed ID: 22670050 [TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial. Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Abitay R; Nurpeisova A; Sagymbay A; Koshemetov Z; Stukova M; Buzitskaya Z; Кulmagambetov I; Karabayeva D; Davlyatshin T; Khairullin B J Med Virol; 2018 Jan; 90(1):41-49. PubMed ID: 28842994 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
6. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. Beran J; Vesikari T; Wertzova V; Karvonen A; Honegr K; Lindblad N; Van Belle P; Peeters M; Innis BL; Devaster JM J Infect Dis; 2009 Dec; 200(12):1861-9. PubMed ID: 19909082 [TBL] [Abstract][Full Text] [Related]
9. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. Mallory RM; Yi T; Ambrose CS Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of inactivated and live attenuated influenza vaccines. Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407 [TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351 [TBL] [Abstract][Full Text] [Related]
12. Influenza virus infections from 0 to 2 years of age: A birth cohort study. Teros-Jaakkola T; Toivonen L; Schuez-Havupalo L; Karppinen S; Julkunen I; Waris M; Peltola V J Microbiol Immunol Infect; 2019 Aug; 52(4):526-533. PubMed ID: 29254653 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024 [TBL] [Abstract][Full Text] [Related]
14. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season. McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121 [TBL] [Abstract][Full Text] [Related]
16. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine. Myers CA; Faix DJ; Blair PJ Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631 [No Abstract] [Full Text] [Related]
17. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18. Pebody R; Djennad A; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Galiano M; Hoschler K; Lackenby A; Robertson C; O'Doherty M; Sinnathamby M; Panagiotopoulos N; Yonova I; Webb R; Moore C; Donati M; Sartaj M; Shepherd SJ; McMenamin J; de Lusignan S; Zambon M Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387673 [TBL] [Abstract][Full Text] [Related]
18. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine. Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124 [TBL] [Abstract][Full Text] [Related]
19. The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children. Ng S; Ip DK; Fang VJ; Chan KH; Chiu SS; Leung GM; Peiris JS; Cowling BJ PLoS One; 2013; 8(3):e59077. PubMed ID: 23554974 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh. Lewis KDC; Ortiz JR; Rahman MZ; Levine MZ; Rudenko L; Wright PF; Katz JM; Dally L; Rahman M; Isakova-Sivak I; Ilyushina NA; Matyushenko V; Fry AM; Lindstrom SE; Bresee JS; Brooks WA; Neuzil KM Clin Infect Dis; 2019 Aug; 69(5):777-785. PubMed ID: 30481272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]